ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Xolair 150 mg/1.0 ml, Injektionslösung in einer Fertigspritze - 
68030002 Novartis Pharma Schweiz AG
Xolair 150 mg/1.0 ml, Injektionslösung in einer Fertigspritze08.04.2021
  08.04.2021
Omalizumab (R03DX05) 
WHO-DDD07.04.2026
03.04.50. 
03.04.50. 
B  
Yes 
IPCI
375.83Yes
    
10 %425.15
7680680300022Biotechnologika
  
Composition
omalizumabum 150.00 mg, arginini hydrochloridum, histidini hydrochloridum monohydricum, histidinum, polysorbatum 20, aqua ad iniectabile q.s. ad solutionem pro 1.00 ml.
Packungsbestandteile
Injection solution in prefilled syringe 
  
 
Active AgentDose
Omalizumab150mg / 1ml
BAG: Active AgentDose
Omalizumab150 mg
 
Inactive agents
Arginine Hydrochloride
Histidin Hydrochloride Monohydrate
Histidine
Polysorbatum 20
 
Source
Data was imported : 06.04.2022 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home